Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1

Helmut M Diepolder ¹, Nobuhito Kashiwagi, Gerlinde Teuber, Axel Ulsenheimer, Marita Franz, Takashi Yokoyama, Reinhart Zachoval, J Med Virol. 2005 Oct;77(2):209-15.

 The results indicate that activation of cellular immunity by leucocytapheresis facilitates an early virological response rate in HCV patients. This new therapy may, therefore, become an additional therapeutic measure for HCV.

https://pubmed.ncbi.nlm.nih.gov/16121358/